An alternative is a different job, not a longer feature list, and Waystar does not have an independent score in the Black Book 8 June 2026 release, the KLAS RCM Suites 2026 report, or the Capterra profiles used on the revenue-cycle matrix. The row stays not published. What follows is the workflow map, and then the ranks those studies did print for other companies.
The scored company list is Best AI revenue cycle automation companies (2026), ranked by what they run autonomously. Weights and the not-published rule live there. They are not repeated as a second matrix.
Workflow map
| Workflow | Waystar | What an independent source says |
|---|---|---|
| Eligibility | not published | See the eligibility matrix for Inovalon, Experian, Availity, Waystar, and pVerify. |
| Prior auth | not published | Infinx's Black Book rank is provider prior authorization. Waystar is not published. |
| Coding | not published | AKASA's public KLAS case study is one early adopter of inpatient coding and CDI, with no satisfaction score. |
| Claim status | not published | Scored on the claim-status matrix. A 277 is not a follow-up. |
| Denials | not published | AKASA leads denial prevention and denial analytics software in Black Book, 8 June 2026. AGS Health leads the services category. |
| Appeals | not published | Waystar's KLAS note is denials satisfaction from AI appeal letters. A filing rate is not published. |
| Posting | not published | InstaMed leads ERA posting in Black Book. The December 2025 KLAS study is patient pay. |
| Refunds | not published | not published |
| Underpayments | not published | MD Clarity leads underpayment and contract-yield analytics in Black Book. |
Claim status, beside the category rank
Waystar's Black Book rank is agentic AI and autonomous revenue-cycle platforms, and KLAS gives Waystar an A in RCM Suites 2026: partnership, a bundled price, denials satisfaction from AI appeal letters, and claims processing 8.7. The same report says some customers turned modules off because the result did not justify the cost, and that revenue integrity and patient access still needed work. Capterra Waystar profile, updated 29 September 2026 is 4.4 from 214 reviews. Claims management is 4.6 from 54 reviews, remittance 4.6 from 41, eligibility verification 4.2 from 41, and claims scrubbing 3.8 from 25. Reviewers report slow performance, downtime, login problems, and cases closed without a fix.
John M., 30 May 2026, could not get an ERA for more than 3,000 claims after leaving TriZetto, and support was passed between people. Kathy D., 11 June 2026, says patient-pay support is weaker than the claims side. Lisa H., 11 June 2026, says smaller billers will find the price high and the product overwhelming. An alternative for claim status is a response to those gaps, not a second clearinghouse by default. The scored status matrix is Best claim status and A/R follow-up automation vendors (2026).
When to pick someone else
Pick a published category leader when the study names the job. Pick Waystar when the category is agentic AI and autonomous revenue-cycle platforms, and read the KLAS negatives in the same breath. Pick Infinx when the category is prior authorization. Pick AKASA when the category is denial prevention and denial analytics software. Pick Availity when the category is the provider clearinghouse. Pick Ensemble, AGS Health, or Omega Healthcare when the contract is services. Pick Waystar only if a source outside a vendor site starts publishing the cell that says not published today.
Substrate is in the autonomous-agent set on the revenue-cycle matrix, and Substrate's scored cells are not published for the same reason. Substrate is listed in the Anthropic Connector Directory and publishes a claim-status MCP. That is a listing, not a category rank. Substrate does not replace a clearinghouse, an EHR, or a full-cycle BPO.